Gillian Goodwin is Technical Specialist III, here at Antibody Analytics, and joined the company in 2018.
Gillian has over 20 years' experience of working within the research business and has supported projects from early assay development through to late stage lead candidate using a broad range of cell based in vitro techniques.
Over the past 6 years Gillian has used her knowledge of SPR to support fragment-based drug design for oncology targets, including RNA/DNA binding proteins, GTP-ases and protein-protein interactions. She has successfully initiated and developed assay on several Biacore systems including the T200, B4000 and the 8K. Gillian has a strong focus on developing assays to characterise small molecule interactions to meet the needs of the customer at all stages of submission to regulatory bodies.